Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging.
about
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's diseaseEnhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's DiseaseAmyloid-beta transporter expression at the blood-CSF barrier is age-dependent.Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months.Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injuryNeurovascular dysfunction and neurodegeneration in dementia and Alzheimer's diseaseIncreased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread.Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype.Road to Alzheimer's disease: the pathomechanism underlying.Is RAGE still a therapeutic target for Alzheimer's disease?Metallostasis and amyloid β-degrading enzymes.Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by moleculaDissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension.The effect of aging on brain barriers and the consequences for Alzheimer's disease development.EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial modelSex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.Aging of cerebral white matter.Glial markers and emotional memory in rats following acute cerebral radiofrequency exposures.The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's diseaseChoroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP.Potential therapeutic system for Alzheimer's disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients.Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Diversity of astroglial responses across human neurodegenerative disorders and brain aging.The blood brain barrier: Insights from development and ageing.Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.Regional Gene Expression of Inflammation and Oxidative Stress Responses Does Not Predict Neurodegeneration in Aging.Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesis.A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease.Reduction of Alzheimer's disease amyloid-β in plasma by hemodialysis and its relation to cognitive functions.Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging.Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier
P2860
Q26800063-27C6D066-BEB5-487A-BA7A-1690A65A6877Q33895840-E6D92113-B3B2-4D19-B099-B17916A7DCF1Q34792995-15F1B72C-B949-4BF5-B3D7-494FF2072031Q35183396-2BC13E62-ABB8-44BD-9831-C8ECF15D7D42Q35742280-76AC887D-D4BA-474C-A2B9-C7A2A040F20AQ36205039-450BC675-5407-4413-886B-62D2EA88E6CCQ36586319-5DDB6748-9224-4346-8457-F98D4A0B1251Q36767796-AFCEC891-DC58-42E8-A77D-70F81BF6884CQ37541359-2406CD34-AC2E-4917-95F2-86E01C72854FQ37824369-FF07E958-732A-4161-8826-DCF9C1380AD0Q37886047-0B472F01-A950-4F7A-88A7-A7138B4BCF31Q37972068-810DEE0D-2BE3-441B-98CC-DA0CFB84730FQ38008724-FB2677C6-59F1-4BC4-B973-493FE4AA2B9AQ38029514-07B64BF6-67BB-4CC3-8B2C-138729FFDBD3Q38260539-B89D11E2-DC6D-42DF-AEEC-6E7AF1D021A7Q38295848-15029BCC-B0B5-42D2-903F-61B8EE4459B6Q38447377-B6D98BF5-AB34-4D6C-8BDC-2E424F67BE1EQ38542827-0B6D3477-5E4E-4DDF-B1DE-C1FA6EAE5A28Q38675820-7EAA3E7E-9D6D-4E68-85F8-0CD8210DDFB8Q38824861-0617BED0-D2EE-43F6-985F-7AA48E7303ADQ38937588-90D44226-00EA-4169-9CB6-0EEC4A859B33Q38955319-0E610EAD-A520-42BA-A06E-5CD58B62C204Q39014387-B067CECA-BD11-44E0-BF5D-0548F1D065DFQ39328965-4F2854A0-C23F-4D7F-B069-FCDE426A65A2Q41215942-ECC19DD2-9C8B-4511-B681-999874B45957Q41907734-338D7934-3D1C-4FF7-9D1D-1C5FAE6146A4Q43074615-61246EEF-645D-49F0-ADE5-9017895DC08FQ44058569-AB1BEEBF-C4B7-4D0F-90DA-F4B0EE37C965Q47743028-837E7EFB-897F-486E-ADEB-5F9E468607F7Q47929663-5C9372C8-A371-4880-9625-CF03B4764063Q48093473-FF8C8F29-13A1-4EAE-996B-B012F5FD6F25Q48222289-FA436467-BE0D-4861-A23F-42BCB0D292E6Q48325532-AB2AB22B-B253-44E0-8794-2FF4F84594C4Q48823269-E874B8EF-EF9F-488D-B093-9171B312D181Q50576467-315FE0F1-23D1-4890-B173-C9ABBDE0C8B2Q51812737-C5A46EF8-5922-4395-8BBE-141B627B1000Q53415989-E0740057-12EE-4450-8142-50C19E333DD9Q57810063-EDA70873-3DC5-4905-B98E-5D2FC092A385
P2860
Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Amyloid deposition and influx ...... rier increase in normal aging.
@en
Amyloid deposition and influx ...... rier increase in normal aging.
@nl
type
label
Amyloid deposition and influx ...... rier increase in normal aging.
@en
Amyloid deposition and influx ...... rier increase in normal aging.
@nl
prefLabel
Amyloid deposition and influx ...... rier increase in normal aging.
@en
Amyloid deposition and influx ...... rier increase in normal aging.
@nl
P2093
P2860
P1476
Amyloid deposition and influx ...... rier increase in normal aging.
@en
P2093
Arthur A Messier
Edward G Stopa
Gerald D Silverberg
John E Donahue
Miles C Miller
Samir Majmudar
P2860
P304
P356
10.1097/NEN.0B013E3181C8AD2F
P577
2010-01-01T00:00:00Z